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a b s t r a c t
A 39-year-old man with a seemingly non-remodeled, small heart suffered persistent atrial ﬁbrillation
(AF). Extensive isolation of the pulmonary vein, superior vena cava, and posterior left atrium, in
conjunction with right atrium focal ablation, was performed to ablate multiple AF foci during two
catheter ablation sessions. Sinus arrest occurred suddenly during follow-up, despite the absence of
recurrent AF, ultimately necessitating pacemaker implantation. This case underscores the necessity of
careful follow-up after catheter ablation, highlighting the risk of sudden, severe sinus node dysfunction,
even in young AF patients with small hearts.
& 2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Several studies have described an association between age or
atrial size and atrial ﬁbrosis [1,2], which may play a role in sinus
node dysfunction. Although catheter ablation (CA) is a standard
treatment for patients with atrial ﬁbrillation (AF) [3], some
patients, who are difﬁcult to identify pre-procedurally, develop
sinus node dysfunction after CA.
2. Case report
A 39-year-old man underwent cardioversion for drug-refrac-
tory, symptomatic AF that had persisted for six months. The
patient was scheduled for CA due to persistent AF burden, despite
anti-arrhythmia therapy. Preoperative echocardiography revealed
no structural heart disease, but revealed a small left atrium (LA;
33 mm) and a sharp left atrial appendage peak ﬂow velocity
(92.8 cm/s), without spontaneous echo contrast. AF was deter-
mined during initial CA to originate from multiple foci including
the pulmonary veins, superior vena cava (SVC), posterior LA, and
right atrium (RA) crista terminalis. Therefore, the SVC was electrically
isolated, the other foci were focally ablated, and extensive circumfer-
ential pulmonary vein isolation was performed without any obvious
complications. Linear ablation was not performed. The patient's
clinical course following cardioversion is described in Table 1.
Although the patient experienced short palpitations, anti-
arrhythmia therapy was discontinued after a three-month blanking
period because objective evidence of arrhythmia was absent. How-
ever, AF recurrence was detected three months later during 24-h
Holter monitoring. Nine months after the initial CA, sudden pre-
syncope occurred due to sinus arrest. During the second CA
performed 15 months later, an electrical reconnection was present
between the LA and SVC, rather than between the LA and the four
pulmonary veins. Isoproterenol drip infusion induced spontaneous
AF initiation from the SVC and multiple foci from the posterior LA
and septal RA. Therefore, the SVC was re-isolated, the posterior LA
was electrically isolated, and the RA foci were focally ablated. The AF
was controlled completely after the second CA, but frequent episodes
of sinus arrest with pre-syncope persisted. Six months after the
second CA, the patient's condition had not improved, and he under-
went pacemaker implantation (PMI). Consequently, his pre-syncope
symptoms disappeared completely.
3. Discussion
The speciﬁc reasons for the patient's sinus arrest are unknown.
However, we speculate that the potential sinus node dysfunction
might have progressed after the initial CA as a natural course in this
patient's morphologically small heart, which is generally considered to
be less remodeled. Masuda et al. [4] reported that PMI was required in
ﬁve (5.0%) of 102 patients (mean age, 68 years) due to sick sinus
syndrome following CA for chronic AF; in these patients, AF had
persisted for approximately ﬁve years. Three of the patients under-
went PMI for brady–tachycardia syndrome with recurrent AF, but two
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required PMI for sinus bradycardia following sinus rhythm restoration
and CA [4]. Sinus node injury due to SVC isolation has been reported in
4.5% of cases, usually immediately after the procedure [5].
This unique case details sudden-onset sinus arrest nine months
after CA treatment in a young patient with a small heart whose AF
had persisted for only six months. It may be inappropriate to
discuss the extent of atrial remodeling at the initial CA without
objective pre-procedural magnetic resonance imaging or intrao-
perative voltage mapping ﬁndings. However, it was found during
the initial CA that the AF originated from multiple foci in the LA
and RA. This suggests that the patient had relatively advanced
atrial electrical remodeling, despite his small heart size. Addition-
ally, a putative injury to the sinus node region, during aggressive
ablation (including SVC isolation), might have caused sinus node
dysfunction, without being immediately evident. The late sequela
of sinus arrest may indicate the progression of non-critical sinus
node dysfunction following the initial CA, leading to a critical
result as a natural course thereafter. Regardless of the reason, the
PMI risk should be explained to AF patients before performing CA,
even to young patients with small hearts without apparent
remodeling. Additionally, careful follow-up should be conducted
to avoid the risk of sudden progression of severe sinus node
dysfunction.
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Table 1
Patient history.
Date Events Memo Mean HR (range),
bpm
Type of AF Maximum R–R
intervals
Type
of SSS
2011/11/21 Cardioversion Recover to normal sinus rhythm (200J)
2012/2/6 Holter ECG AADs (bisoprolol and ﬂecainide) 74 (50–186) PAF 1.8 –
2012/2/7 First CA PVI, SVCI, and focal ablation (posterior LA and RA crista)
2012/5/11 Holter ECG AADs (bisoprolol and ﬂecainide) 85 (64–125) Short PAF 1.1 –
2012/8/10 Holter ECG AADs (bisoprolol) 87 (52–123) PAF 1.6 –
2012/11/9 Holter ECG AADs (bisoprolol) 90 (30–127) PAF 6 II
2013/4/5 Holter ECG No AADs 107 (32–226) PAF 6.3 II
2013/5/16 Second CA Re-SVCI, posterior LAI, posteroseptal RA focal ablation
2013/5/17 Holter ECG No AADs 89 (57–113) – 4.8 II
2013/5/22 Holter ECG No AADs 85 (55–136) – 5.7 II
2013/6/28 Holter ECG No AADs 85 (52–127) – 6.4 II
2013/9/6 Holter ECG No AADs 86 (28–150) – 7.6 II
2013/9/27 PMI VVI mode
2014/1/10 Holter ECG No AADs 93 (60–155) – 1.3 –
2014/4/4 Holter ECG No AADs 92 (64–141) – 1.3 –
AADs, antiarrhythmic drugs; AF, atrial ﬁbrillation; CA, catheter ablation; ECG, electrocardiogram; HR, heart rate; LA, left atrium; LAI, left atrial isolation; PAF, paroxysmal
atrial ﬁbrillation; PMI, pacemaker implantation; PVI, pulmonary vein isolation; RA, right atrium; SSS, sick sinus syndrome; SVCI, superior vena cava isolation.
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